Press Coverage: Williams Companies Stockholder Litigation Trial Challenging Novel Anti-Shareholder Corporate Governance Provision
January 13, 2021The BLB&G trial team of Mark Lebovitch, Gregory V. Varallo, and Thomas James challenged a novel anti-shareholder corporate governance provision in Delaware Chancery Court.
This closely-watched trial marks the first full-blown challenge to the most recent—and harmful—poison pill developments.
Press coverage of the case is highlighted in the links below, and can also be accessed in the PDFs. More information about the case can be accessed using the Related Case link on the left-hand sidebar.
PDFs of Article
Links to Article
Also of Interest
BLB&G Allianz Structured Alpha Funds Team Announces New Case Filing
October 16, 2020
BLB&G Partner Mark Lebovitch Quoted in Fortune magazine on Business Roundtable’s Repudiation of Shareholder Primacy
Forbes Highlights Pivotal Role of Private Shareholder Litigation in Checking Corporate Misconduct
June 29, 2018
BLB&G Announces Elevation of Two Partners and Four Senior Counsel
January 24, 2020
BLB&G Named 2020 Top Securities Practice by Law360
November 30, 2020
Hans Ek Joins BLB&G's European Team in Stockholm
October 1, 2020
BLB&G’s Mark Lebovitch Selected an Adviser on ALI’s “Restatement of the Law, Corporate Governance” Project
April 1, 2019
Columbia Law Review Article on Sexual Harassment and Corporate Law Cites BLB&G’s Celebrated 21st Century Fox Litigation
June 18, 2018
BLB&G Opens New Delaware Office Led by Top Litigator and New Partner Greg Varallo